• 1
    Cabrer C, Manyalich M, Valero R, García-Fages LC. Timing used in the different phases of the organ procurement process. Transplant Proc 1992; 24: 2223.
  • 2
    Miranda B, Cañón J, Cuende N. The Spanish organizational structure for organ donation: update. Tranplant Rev 2001; 15: 3345.
  • 3
    Darby JM, Stein K, Grenvik A, Stuart S. Approach to management of the heartbeating brain dead organ donor. JAMA 1989; 261: 22222228.
  • 4
    Wheeldon DR, Potter CDO, Oduro A, Wallwork J, Large SR. Transforming the ‘unacceptable’ donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 1995; 14: 734742.
  • 5
    Rosendale JD, Chabalewski FL, McBride MA et al. Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant 2002; 2: 761768 .
  • 6
    Mackersie RC, Bronsther LO, Shackford SR. Organ procurement in patients with fatal head injuries. Ann Surg 1991; 213: 143150.
  • 7
    Nygaard CE, Townsend RN, Diamond DL. Organ donor management and organ outcome: a 6-year review from a level I trauma center. J Trauma 1990; 30: 728732.
  • 8
    Valero R, Manyalich M, Cabrer CA, García-Fages LC. Mantenimiento del donante de órganos. Rev Esp Anestesiol Reanim 1992; 39 (5): 293300.
  • 9
    Gelb AW, Robertson KM. Anaesthetic management of the brain dead for organ donation. Can J Anaesth 1990; 37: 806812.
  • 10
    Gortmaker SL, Beasley CL, Brigham LE et al. Organ donor potential and performance: size and nature of the organ donor shortfall. Crit Care Med 1996; 24: 432439.
  • 11
    Razek T, Olthoff K, Reilly PM. Issues in potential organ donor management. Surg Clin N Am 2000; 80: 10211032.
  • 12
    Wheeldon DR, Potter CD, Dunning J et al. Haemodynamic correction in multiorgan donation. Lancet 1992; 339: 1175.
  • 13
    Salim A, Vassiliu P, Velmahos GC et al. The role of thyroid hormone administration in potential organ donors. Arch Surg 2001; 136: 13771380.
  • 14
    García-Fages LC, Cabrer CA, Valero R, Manyalich M. Hemodynamic and metabolic effects of substitutive triiodothyronine therapy in organ donors. Transplant Proc 1993; 25: 30383039.
  • 15
    Goarin JP, Cohen P, Riou B et al. The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors. Anesth Analg 1996; 83: 4147.
  • 16
    Scheinkestel CD, Tuxen DV, Cooper DJ, Butt W. Medical management of the (potential) organ donor. Anaesth Intens Care 1995; 23: 5159.
  • 17
    Wijnen RMH, Van Der Linden CJ. Donor treatment after pronouncement of brain death: a neglected intensive care problem. Transplant Int 1991; 4: 186190.
  • 18
    Schnuelle P, Berger S, De Boer J, Persijn G, Van Der Woude FJ. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation 2001; 72: 455463.
  • 19
    Lopez Navidad A, Domingo P, Caballero F. Organ shortage. Viability of potential organ donors and possible loss depend on health care workers who are responsible for the organ procurement program. Transplant Proc 1997; 29: 36143616.
  • 20
    Handley AJ, Monsieurs KG, Bossaert LL. European resuscitation council guidelines 2000 for adult basic life support. A statement from the Basic Life Support and Automated External Defibrillation Working Group (1) and approved by the Executive Committee of the European Resuscitation Council. Resuscitation 2001; 48: 199205.DOI: 10.1016/s0300-9572(00)00377-4
  • 21
    Caplan R, Benumof JL, Berry FA et al. Practice guidelines for management of the difficult airway: a report by the ASA Task Force on Management of the Difficult Airway. Anesthesiology 1993; 78: 597602.
  • 22
    Jenkins DH, Reilly PM, Schwab CW. Improving the approach to organ donation: a review. World J Surg 1999; 23: 644649.
  • 23
    Luskin M, Buckley CA, Bradley JW, O'Connor KJ, Delmonico FL. An alternative approach to evaluating organ procurement organization performance. Transplant Proc 1999; 31: 353355.